The Deputy Commissioner of the China FDA (CFDA), Yin Li, met with representatives of the European Commission Health and Consumer Policy Committee and the Directorate General for Health and Consumer...read more

Anvisa has launched a public consultation on a proposal to define the list of products eligible for simplified registration that may be registered as herbal medicines or as traditional herbal produ...read more

The Board of Brazil’s National Health Surveillance Agency (Anvisa) has approved the launch of a public consultation on traditional Chinese medicine, the purpose of which is to determine the s...read more

The China FDA issued a notice on May 9 setting deadlines for implementing electronic monitoring of essential drugs for imported drugs. Imported drugs in domestic packaging must comply with electron...read more

The House hearing on the scope of regulatory authority of Brazil’s National Health Surveillance Agency (Anvisa) on May 9 was an initiative of the Committee on Social Security and Family of th...read more

The House hearing on the scope of regulatory authority of Brazil’s National Health Surveillance Agency (Anvisa) on May 9 was an initiative of the Committee on Social Security and Family of th...read more

China’s FDA issued a instructions to the Provinces on May 7 with attached forms on the requirements for certifying active pharmaceutical ingredient manufacturers for the right to export to th...read more

Brazil’s National Health Surveillance Agency (Anvisa) proposed to the country’s municipal mayors that local regulatory agencies act as facilitating agents for local entrepreneurs, rural...read more

The Commissioner of China’s State Food and Drug Administration (SFDA), Yin Li, met with the Ambassador of Austria to China, Dr. Irene Giner-Reichl, on January 24.  The bilateral discussi...read more